KSR1绝杀鼠标模型证明了MAPK途径在西斯普拉丁和噪音引起的听力损失中的关键作用
Matthew A Ingersoll1, Richard D Lutze1, Regina G Kelmann1
1Departments of Pharmacology and Neuroscience, Creighton University, Omaha, Nebraska 68178.
概括
消除RAS 1 (KSR1) 的蛋白激酶抑制剂或抑制MAPK通路保护小鼠免受西斯和噪音引起的听力损失. 这为保护和治疗听力提供了潜在的战略.
科学领域:
- 耳鼻喉科 耳鼻喉科 耳鼻喉科
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 听力损失是一种严重的残疾,需要治疗干预.
- 线素激活蛋白激酶 (MAPK) 途径与耳细胞损伤有关.
- RAS 1 (KSR1) 的蛋白激酶抑制剂在MAPK通路中充当支架蛋白.
研究的目的:
- 调查KSR1在西斯和噪音引起的听力损失中的作用.
- 评估KSR1删除和MAPK通路抑制对听觉的保护作用.
主要方法:
- 产生了KSR1淘汰赛 (KO) 的小鼠.
- 暴露于KSR1 KO和野生型小鼠的西斯普拉丁和噪音.
- 给野生型和KSR1 KO小鼠使用BRAF抑制剂达布拉费尼布.
- 在测试频率中使用声级 (dB SPL) 评估听力保护.
主要成果:
- 在KSR1淘汰的小鼠中,表现出对西斯普拉丁和噪音引起的听力损失的抵抗力.
- 在耳细胞中,KSR1缺失减弱的MAPK酸化级联.
- 达布拉菲尼布治疗保护了野生型小鼠的听力损失,但没有增强KSR1KO小鼠的保护.
- 在KSR1缺乏的小鼠中,听力保护达到了高达30dB的SPL.
结论:
- KSR1在调解西斯和噪音引起的听力损失方面发挥着至关重要的作用.
- 通过KSR1删除或达布拉费尼布抑制MAPK通路,可以显著地保护听力.
- 准MAPK途径是一个有希望的治疗策略,用于预防和治疗听力损失.
相关概念视频
01:07MAPK Signaling Cascades
5.5K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.5K
01:16In-vitro Mutagenesis
13.9K
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
13.9K